Tivicay Oral Tablet 50Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

TIVICAY: Oral tablet (50mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_17207.JPG
TIVICAY 50mg Tablet
ViiV Healthcare a GSK and Pfizer Company
Pill Identification: SV 572  |  50

What is this Medicine?

DOLUTEGRAVIR (doe loo teg ra veer) is an antiretroviral medicine. It is used with other medicines to treat HIV. This medicine is not a cure for HIV. It will not stop the spread of HIV to others.

In-Depth Information

TIVICAY 50mg Tablet

NDC: 497020228
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Human Immunodeficiency Virus (HIV) Infection

Sometimes used for but not FDA approved for the following conditions:
Human Immunodeficiency Virus (HIV) Prophylaxis

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
TIVICAY 50mg Tablet
Drug Image file DrugItem_17207.JPG
ViiV Healthcare a GSK and Pfizer Company
Pill Identification: SV 572  |  50
Shape: round
Color: yellow

Reported Side Effects for TIVICAY 50mg Tablet

Upset Stomach Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Rash With Pustules Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Thoughts Of Suicide Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Liver Infection Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
<2.0%*
Severity: MILD
Onset: RAPID
Inability To Sleep Incidence:
<7.0%*
Severity: MILD
Onset: EARLY
High Bilirubin Level Incidence:
<3.0%*
Severity: MODERATE
Onset: DELAYED
Headache Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Gas Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Tired Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Depression Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
1.0-18.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cells Incidence:
2.0-4.0%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Sugar Incidence:
6.0-14.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for TIVICAY 50mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Alcohol and TIVICAY 50mg Tablet(Dolutegravir)
Alcohol and Dolutegravir(Dolutegravir)
Do not take these together without approval from your prescriber. Discuss possible alternative treatment options with your health care provider. Taking these together may decrease the effectiveness of dolutegravir.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with TIVICAY

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5